Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.
about
A prospective surveillance model for rehabilitation for women with breast cancerDiphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.Lymphatic mapping and lymphedema surgery in the breast cancer patientTopical tacrolimus for the treatment of secondary lymphedema.Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trialsBlockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.Biomaterial guides for lymphatic endothelial cell alignment and migrationRadiation-induced impairment in lung lymphatic vasculatureBridging the divide between pathogenesis and detection in lymphedema.Fibrosis worsens chronic lymphedema in rodent tissuesLymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines.Regulation of inflammation and fibrosis by macrophages in lymphedema.TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)Management of radiation wounds.Unintended irradiation of internal mammary chain - Is that enough?Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema.The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.The Lymphatic System in Disease Processes and Cancer ProgressionInterleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage.Vascular endothelial growth factor-C enhances radiosensitivity of lymphatic endothelial cells.Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.Mechanisms of radiation-induced skin injury and implications for future clinical trials.The use of antioxidants in radiotherapy-induced skin toxicity.Lymphedema surgery: Patient selection and an overview of surgical techniques.MR lymphangiography in the treatment of lymphedema.Transcriptome Alterations In X-Irradiated Human Gingiva Fibroblasts.Longitudinal monitoring of the head and neck lymphatics in response to surgery and radiation.Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: A feasibility study.Improved regeneration of autologous transplanted lymph node fragments by VEGF-C treatment.Skin indentation firmness and tissue dielectric constant assessed in face, neck, and arm skin of young healthy women.
P2860
Q27010396-8D0AC8C3-3E82-4817-9E2B-874B400C15B2Q27334274-BC572600-46BD-465B-BC6D-9F88FA308911Q28085387-6B2BA2BB-5479-44B1-8781-245634FA3474Q30838687-F8FE292C-D1A1-4FC3-89F3-C540902E9C0FQ34325432-261895C1-3839-4BCF-B0C5-25ECEB85FC3BQ34358339-321A0CDB-C040-4CE9-B440-ACD248AAE8B7Q34490750-DB963BF2-7A72-4B34-A05D-F9F452C7C718Q34543185-27A78839-FFF4-4DC6-B293-C22C1C0C0C7BQ34707886-58568EBB-8555-442C-AA11-0471049CC41BQ35566114-3180B77C-FDE4-4274-875B-B0D7020B3202Q35622411-89512889-ABF6-42BC-83BD-544F6E7CB708Q35895537-18BB08BA-776A-4B72-B77E-D2AB4C786738Q36000031-94716094-203E-411F-ADB8-2AC6F5B2DB99Q36121570-7AB28AFA-9100-4AB2-A6EF-4E0DE1E0C183Q36391099-18E1A027-76FC-4E7B-A6BF-5B9A4EC1A442Q36472587-07076F19-75EC-4EB0-8DEE-72FDE821D4A2Q36615191-97A5253D-2164-490E-B9C3-15A4596DA4E6Q36685757-C6A7E88B-1293-4B4B-8AF2-1102EE1A55A7Q36968316-F773746D-0C2E-4FFD-8D05-C0609C8EF8B5Q37099065-FFAF0D53-0985-488E-9793-E6A4034D88F5Q37635188-1A870162-9674-4B87-BE3A-502C31F10060Q37695046-1574A973-39F9-4523-B40E-B2E355E4D8DCQ37954544-561CDCD3-1FAE-402C-A17E-6B92F5F1DA3BQ38072978-7C17DCC6-4B4C-4F31-8CDC-571FBF04BE27Q38111318-22FE216F-EFE2-4449-A572-5F4D7D58B933Q38723381-5C1E47FD-6B19-4FAD-8E33-4C3D165CC6AAQ38885931-2FBBC5CC-3F91-4065-9489-D493D6BA5AC4Q39645601-8DF0D056-2388-4EF1-B164-3BFAB830490AQ48160790-A0C5AACE-4CB5-40A6-9A6A-2430FD78C3D0Q48316611-AFD9179E-0CB4-4992-BF5A-BFDD6BC11613Q50250014-F9932CC7-8A4F-47D7-AADC-DE239B28FC73Q53777005-40D8B3C8-BADD-4D74-B403-9CEE2688D631
P2860
Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@ast
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@en
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@nl
type
label
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@ast
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@en
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@nl
prefLabel
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@ast
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@en
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@nl
P2093
P2860
P1476
Radiation therapy causes loss ...... eta1-mediated tissue fibrosis.
@en
P2093
Andrew P Cordeiro
Babak J Mehrara
Jamie C Zampell
Sanjay V Daluvoy
Tomer Avraham
P2860
P304
P356
10.1152/AJPCELL.00535.2009
P577
2010-06-02T00:00:00Z